当前位置:首页 - 行情中心 - 莱茵生物(002166) - 财务分析 - 现金流量表

莱茵生物

(002166)

  

流通市值:33.61亿  总市值:55.70亿
流通股本:4.48亿   总股本:7.42亿

现金流量表

报告期2024-12-312024-09-302024-06-302024-03-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金1,888,280,454.121,438,826,870.38995,017,866.44627,894,881.41
收到的税费返还70,908,816.4566,130,272.4452,061,988.2528,800,106.01
收到其他与经营活动有关的现金22,652,31816,738,483.9712,515,446.519,004,937.95
经营活动现金流入的平衡项目0000
经营活动现金流入小计1,981,841,588.571,521,695,626.791,059,595,301.2665,699,925.37
购买商品、接受劳务支付的现金1,415,577,326.371,047,088,689.31779,012,147.79476,753,334.68
支付给职工以及为职工支付的现金185,707,033.63136,483,035.2292,039,609.2850,802,614.11
支付的各项税费53,134,538.1836,851,920.4726,225,151.5611,220,146.68
支付其他与经营活动有关的现金167,709,093.35158,535,527.71132,700,934.43111,147,194.57
经营活动现金流出的平衡项目0000
经营活动现金流出小计1,822,127,991.531,378,959,172.711,029,977,843.06649,923,290.04
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额159,713,597.04142,736,454.0829,617,458.1415,776,635.33
二、投资活动产生的现金流量:
收回投资收到的现金4,124,071.862,496,073.11--
取得投资收益收到的现金7,362,916.27,362,916.1249,563.12-
处置固定资产、无形资产和其他长期资产收回的现金净额109,03059,48024,308950
投资活动现金流入的平衡项目0000
投资活动现金流入小计11,596,018.069,918,469.2373,871.12950
购建固定资产、无形资产和其他长期资产支付的现金207,081,135.72157,657,032.66107,889,752.9270,478,201.46
投资活动现金流出的平衡项目0000
投资活动现金流出小计207,081,135.72157,657,032.66107,889,752.9270,478,201.46
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-195,485,117.66-147,738,563.43-107,815,881.8-70,477,251.46
三、筹资活动产生的现金流量:
取得借款收到的现金942,894,636833,756,045538,076,045211,606,225
收到其他与筹资活动有关的现金319,100,00018,900,00018,900,000-
筹资活动现金流入平衡项目0000
筹资活动现金流入小计1,261,994,636852,656,045556,976,045211,606,225
偿还债务支付的现金703,570,255498,584,059214,675,11189,701,225
分配股利、利润或偿付利息支付的现金190,320,195.79179,781,071.39166,475,299.979,123,595.98
支付其他与筹资活动有关的现金397,863,799.9284,937,059.3672,228,633.6158,085,208.69
筹资活动现金流出平衡项目0000
筹资活动现金流出小计1,291,754,250.71763,302,189.75453,379,044.58156,910,029.67
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-29,759,614.7189,353,855.25103,597,000.4254,696,195.33
四、汇率变动对现金及现金等价物的影响1,636,118.971,297,474.72993,987.76178,429.45
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-63,895,016.3685,649,220.6226,392,564.52174,008.65
加:期初现金及现金等价物余额113,664,422.71113,664,422.71113,664,422.71110,718,019.51
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额49,769,406.35199,313,643.33140,056,987.23110,892,028.16
补充资料:
净利润167,173,992.57-67,995,492.28-
资产减值准备21,463,296.06--2,610,068.48-
固定资产和投资性房地产折旧94,197,003.43-42,478,278.67-
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧94,197,003.43-42,478,278.67-
无形资产摊销4,589,958.37-2,218,013.59-
长期待摊费用摊销4,253,880.75-2,690,507.74-
处置固定资产、无形资产和其他长期资产的损失523,831.47-8,561-
固定资产报废损失1,116,976.43-571,015.99-
公允价值变动损失-2,025,062.21-4,502,537.93-
财务费用41,281,141.03-18,557,483.53-
投资损失-7,178,829--7,362,916.12-
递延所得税951,847.94-452,468.66-
其中:递延所得税资产减少-2,820,177.9--1,909,404.64-
递延所得税负债增加3,772,025.84-2,361,873.3-
存货的减少-237,129,675--277,353,623.89-
经营性应收项目的减少8,251,296.59-198,579,865.41-
经营性应付项目的增加42,370,133.3--22,831,180.58-
其他16,076,345.8---
现金的期末余额49,769,406.35-140,056,987.23-
减:现金的期初余额113,664,422.71-113,664,422.71-
公告日期2025-03-282024-10-312024-08-292024-04-27
审计意见(境内)标准无保留意见
TOP↑